Metabolomic Approach to Screening Homozygotes in Chinese Patients with Severe Familial Hypercholesterolemia

Metabolomic Approach to Screening Homozygotes in Chinese Patients with Severe Familial Hypercholesterolemia

Homozygous familial hypercholesterolemia (HoFH) is a rare inborn-errors-of-metabolism disorder characterized by devastatingly elevated low-density lipoprotein cholesterol (LDL-C) and premature cardiovascular disease. The gold standard for screening and diagnosing HoFH is genetic testing. In China, i...

Full description

Bibliographic Details
Main Authors:	Zhiyong Du, Yunhui Du, Linyi Li, Haili Sun, Chaowei Hu, Long Jiang, Luya Wang, Yanwen Qin
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Series:	Journal of Clinical Medicine
Subjects:	homozygous familial hypercholesterolemia severe heterozygous familial hypercholesterolemia metabolomics diagnostic markers
Online Access:	https://www.mdpi.com/2077-0383/12/2/483

Similar Items

The panorama of familial hypercholesterolemia in Latin America: a systematic review[S]
by: Roopa Mehta, et al.
Published: (2016-12-01)

Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia
by: Zhiyong Du, et al.
Published: (2023-07-01)

Familial homozygous hypercholesterolemia with arcus cornea and xanthomas: A rare but serious entity
by: Amal Chamli, et al.
Published: (2023-03-01)

Homozygous familial hypercholesterolemia
by: Ravi Kumar Parihar, et al.
Published: (2012-01-01)

Real‐World Effectiveness of PCSK9 Inhibitors in Reducing LDL‐C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries
by: Marcello Arca, et al.
Published: (2023-11-01)

Variable and Severe Phenotypic Expression of the “Lebanese Allele” in Two Sisters with Familial Hypercholesterolemia
by: Chahine J, et al.
Published: (2021-07-01)

Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study
by: Kasper Aalbæk Kjærgaard, et al.
Published: (2022-07-01)

Homozygous familial hypercholesterolemia: modern aspects of pathogenesis, diagnostics and treatment
by: V. К. Zafiraki, et al.
Published: (2018-10-01)

Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
by: Akl C. Fahed, et al.
Published: (2012-11-01)

Homozygous familial hypercholesterolemia with stenosis of the left anterior descending coronary artery successfully treated with weekly low‐density lipoprotein apheresis for 16 years without percutaneous coronary intervention
by: Takanori Yasu, et al.
Published: (2019-08-01)

Spectrum of cardiovascular manifestations in homozygous familial hypercholesterolemia
by: Nitin Bajaj, et al.
Published: (2023-01-01)

Cataract Surgery in Elderly Subjects with Heterozygous Familial Hypercholesterolemia in Prolonged Treatment with Statins
by: Victoria Marco-Benedí, et al.
Published: (2021-08-01)

The burden of severe hypercholesterolemia and familial hypercholesterolemia in a population-based setting in the US
by: Seyedmohammad Saadatagah, et al.
Published: (2022-12-01)

Phenotypic homozygous familial hypercholesterolemia successfully treated with proprotein convertase subtilisin/kexin type 9 inhibitors
by: Ryosuke Tani, et al.
Published: (2024-02-01)

Current causes of death in familial hypercholesterolemia
by: Victoria Marco-Benedí, et al.
Published: (2022-08-01)

Long‐Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening
by: Kasper Aalbæk Kjærgaard, et al.
Published: (2017-11-01)

Myocardial strain impairment, heterozygous familial hypercholesterolemia and systemic arterial hypertension: Is there a link?
by: Antonio Vitarelli
Published: (2021-06-01)

Autosomal Recessive Hypercholesterolemia Caused by a Novel LDLRAP1 Variant and Membranous Nephropathy in a Chinese Girl: A Case Report
by: Siqin Feng, et al.
Published: (2022-02-01)

The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry
by: Hui-Wei Shi, et al.
Published: (2020-07-01)

Corrigendum: The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry
by: Hui-Wei Shi, et al.
Published: (2020-08-01)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
by: Estíbaliz Jarauta, et al.
Published: (2020-12-01)

Case Report: Difficulties in the Treatment of a 12-Year-Old Patient With Homozygous Familial Hypercholesterolemia, Compound Heterozygous Form − 5 Years Follow-Up
by: Lyudmila Vladimirova-Kitova, et al.
Published: (2021-10-01)

Familial Hypercholesterolemia: From Clinical Suspicion to Novel Treatments
by: Saeid Mirzai, et al.
Published: (2023-11-01)

Treatment with PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia Lowers Plasma Levels of Platelet-Activating Factor and Its Precursors: A Combined Metabolomic and Lipidomic Approach
by: Alessandro Di Minno, et al.
Published: (2021-08-01)

Xanthomas Regression in an 8-Year-Old Boy Treated With Lomitapide
by: Genovefa Kolovou, MD, PhD, et al.
Published: (2019-10-01)

Family and polygenic hypercholesterolemia: similarities and differencies by long-term follow-up
by: B M Lipovetskiy, et al.
Published: (2009-03-01)

Premature Coronary Artery Disease due to Homozygous Familial Hypercholesterolemia in a 12-Year-Old Girl
by: Filiz Ekici, et al.
Published: (2018-03-01)

The prevalence of familial hypercholesterolemia in teenagers from Timișoara
by: Andreea Dumitrescu¹,²,, et al.
Published: (2016-12-01)

Role of lipoprotein apheresis in the management of familial hypercholesterolemia
by: Shamanna Seshadri Iyengar, et al.
Published: (2021-01-01)

Effect of causative genetic variants on atherosclerotic cardiovascular disease in heterozygous familial hypercholesterolemia patients
by: Anthony Matta, et al.
Published: (2023-07-01)

Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia
by: Jean Ferrières, et al.
Published: (2022-12-01)

A Case Report of Homozygous Familial Hypercholesterolemia Liver Transplantation
by: CHEN Peipei, et al.
Published: (2023-01-01)

Difficult Journey to Find the Best Treatment for Homozygous Familial Hypercholesterolemia: Case Report
by: Xu MJ, et al.
Published: (2022-03-01)

Percutaneous Coronary Intervention in Familial Hypercholesterolemia Is Understudied
by: Leo Ungar, et al.
Published: (2018-08-01)

Familial hypercholesterolemia revealed by multiple xanthomas
by: Nassiba Elouarradi, et al.
Published: (2018-05-01)

Clinical Evaluation Of Evolocumab For The Treatment Of Homozygous Familial Hypercholesterolemia In Chinese Patients
by: Huang CC, et al.
Published: (2019-10-01)

Identifying Markers of Cardiovascular Event-Free Survival in Familial Hypercholesterolemia
by: Etienne Khoury, et al.
Published: (2020-12-01)

Perioperative Management and Clinical Outcomes of Liver Transplantation for Children with Homozygous Familial Hypercholesterolemia
by: Huan-Rong Qiu, et al.
Published: (2022-10-01)

Clinical case of myocardial infarction with unspecified familial hypercholesterolemia
by: Natalya G. Lozhkina, et al.
Published: (2022-01-01)

Patient experiences align with the familial hypercholesterolemia global call to action
by: Laney K. Jones, et al.
Published: (2022-06-01)